This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Mendus Gelecekteki Büyüme

Future kriter kontrolleri 5/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Mendus.

Anahtar bilgiler

76.4%

Kazanç büyüme oranı

89.7%

EPS büyüme oranı

Biotechs kazanç büyümesi45.6%
Gelir büyüme oranı81.3%
Gelecekteki özkaynak getirisin/a
Analist kapsamı

Low

Son güncelleme03 Aug 2023

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

Kazanç ve Gelir Büyüme Tahminleri

OM:IMMU BTU - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (SEK Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/2025N/A-32-32-321
12/31/20242591313993992
12/31/2023N/A-139-151-1512
3/31/20231-141-123-119N/A
12/31/20223-139-121-109N/A
9/30/20222-128-124-114N/A
6/30/20222-117-126-114N/A
3/31/20222-119-123-114N/A
12/31/20210-133-139-138N/A
9/30/2021N/A-148-130-129N/A
6/30/2021N/A-138-112-111N/A
3/31/20210-119-91-90N/A
12/31/2020N/A-89-57-57N/A
9/30/20201631113N/A
6/30/202016-11-7-5N/A
3/31/202017-31-22-21N/A
12/31/201917-48-58-58N/A
9/30/20190-118-114-114N/A
6/30/20190-112-102-102N/A
3/31/2019N/A-98-89-89N/A
12/31/2018N/A-98-105-105N/A
9/30/2018N/A-90-88-88N/A
6/30/2018N/A-89-89-89N/A
3/31/2018N/A-88-94-94N/A
12/31/2017N/A-80-46-46N/A
9/30/2017N/A-86-76-76N/A
6/30/2017N/A-77-75-75N/A
3/31/2017N/A-72-68-68N/A
12/31/2016N/A-61N/A-59N/A
9/30/2016N/A-48N/A-51N/A
6/30/2016N/A-44N/A-40N/A
3/31/2016N/A-37N/A-33N/A
12/31/2015N/A-38N/A-35N/A
9/30/2015N/A-37N/A-37N/A
6/30/2015N/A-36N/A-40N/A
3/31/2015N/A-33N/A-33N/A
12/31/2014N/A-28N/A-24N/A
9/30/2014N/A-21N/A-18N/A
6/30/2014N/A-16N/A-9N/A
3/31/2014N/A-13N/A-11N/A
12/31/2013N/A-10N/A-10N/A
9/30/2013N/A-8N/A-7N/A
6/30/2013N/A-7N/A-7N/A
3/31/20130-6N/A-6N/A
12/31/20120-5N/A-6N/A
9/30/20120-5N/A-5N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: IMMU BTU is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.7%).

Kazançlar ve Piyasa: IMMU BTU is forecast to become profitable over the next 3 years, which is considered above average market growth.

Yüksek Büyüme Kazançları: IMMU BTU is expected to become profitable in the next 3 years.

Gelir ve Pazar: IMMU BTU's revenue (81.3% per year) is forecast to grow faster than the Swedish market (1.9% per year).

Yüksek Büyüme Geliri: IMMU BTU's revenue (81.3% per year) is forecast to grow faster than 20% per year.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: Insufficient data to determine if IMMU BTU's Return on Equity is forecast to be high in 3 years time


Büyüyen şirketleri keşfedin